Liver cancer is the fourth leading cause of cancer deaths globally, of which hepatocellular
carcinoma (HCC) is the major subtype. Viral hepatitis B and C infections, alcohol abuse, and …

Remarkable progress has been made in the treatment and control of hepatitis B and C viral
infections. However, fundamental treatments for diseases in which liver fibrosis is a key …

Background Using a toxin-induced nonhuman primate model of acute liver failure (ALF), we
previously reported that peripheral infusion of human umbilical cord mesenchymal stem …

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), is an infectious disease with multiple severe symptoms, such …

Abstract Background Hepatitis B virus (HBV) is one of the major risk factors of hepatocellular
carcinoma (HCC). Increasing evidence indicates that microRNA (miRNA)–mRNA axis is …

People living with hepatitis B virus (HBV) chronic infection are exposed to high rates of liver
complications including end-stage liver disease and hepatocellular carcinoma. Extrahepatic …

The incidence and mortality of hepatitis B virus (HBV)-associated hepatocellular carcinoma
(HBV-HCC) is an intractable public health problem in developing countries that is …

Lung cancer is the most common incident cancer, with a high mortality worldwide, and non‐
small‐cell lung cancer (NSCLC) accounts for approximately 85% of cases. Numerous …

Chronic hepatitis B virus (HBV) infection is a major global public health risk that threatens
human life and health, although the number of vaccinated people has increased. The …

Liver fibrosis is a common pathological process of end-stage liver diseases. However, the
role of microRNA (miRNA) in liver fibrosis is poorly understood. The activated hepatic …